# Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis

> **NCT03230058** · PHASE2,PHASE3 · UNKNOWN · sponsor: **L.V. Prasad Eye Institute** · enrollment: 55 (estimated)

## Conditions studied

- Infection, Fungal

## Interventions

- **DRUG:** Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops

## Key facts

- **NCT ID:** NCT03230058
- **Lead sponsor:** L.V. Prasad Eye Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2018-03-01
- **Final completion:** 2018-09-30
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2017-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230058, "Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03230058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*